This position paper provides insights regarding Pharma Corporate Strategy and covers the following key issues:
- Why and how to elaborate a robust Strategic Square?
- How to select the strategic segments where to play?
- What are the most attractive strategic segments and countries?
- How to evaluate the corporate strategy opportunities?
- What are the corporate BD&L benefits / alternatives?